GSK Q2 Earnings Call Highlights
Key Points Interested in GSK PLC Sponsored ADR? Here are five stocks we like better. GSK reported solid…
GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance
GSK had never won FDA approval for a lung cancer drug — not in decades of trying. Then,…
GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet
Just days after completing a $10.6bn takeover of lung cancer biotech Nuvalent, GSK is already reaping the rewards…
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends…
Nuvalent director’s awards cashed out in GSK deal
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
Nuvalent director tenders shares in $124 GSK buyout
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
GSK Completes Nuvalent Tender Offer at $124 Per Share | NUVL SEC Filing
This Amendment No. 4 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
Nuvalent takeover: HSR waiting period cleared, $124 per share offer | GSK SEC Filing
This Amendment No. 3 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GSK offers $124 per share to acquire Nuvalent | NUVL SEC Filing
This Amendment No. 2 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. GSK plc…
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. GSK plc…
GSK launches $124-per-share Nuvalent tender offer | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…